Iron sucrose in treatment of anemia in chronic kidney disease - original and generic drugs: what are the guidelines in drug choose?
- Authors: Milovanov Y.S1, Milovanova LY.1, Dobrosmyslov IA1, Milovanov Y.S1, Milovanova LY.1, Dobrsmislov IA1
-
Affiliations:
- Issue: No 1 (2012)
- Pages: 49-50
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/261678
- ID: 261678
Cite item
Full Text
Abstract
Keywords
About the authors
Yu S Milovanov
L Yu Milovanova
I A Dobrosmyslov
Yu S Milovanov
L Yu Milovanova
I A Dobrsmislov
References
- Николаев А.Ю., Милованов Ю.С. Лечение почечной недостаточности. Руководство для врачей. 2-е издание. МИА. 2011. 589 с.
- Toblli J.E., Cao G., Oliveri L. et al. Differences between the original iron sucrose complex Venofer and the iron sucrose similar generis, and potential implications. Port. J. Nephrol. Hypert. 2009; 23: 53-63
- Toblli J.E., Cao G., Oliveri L. et al. Differences between the original intravenosus iron sucrose and iron sucrose similar preparations. Drug. Res. 2009; 59: 176-190
- Jacques R., Ahmed K., Emmanuelle L., Aurelie D. Сравнение эффективности двух внутривенных препаратов сахарата железа. Nеphrol. Dial. Transplant. 2011; 1: 1-6
- Goldberg L.A. Iron sucrose similar. Host. Pharm. Eur. 2010; 48: 21-22
- Schellekens U., Klinger E., Muhlebach S. et al. The therapeutic equivalence of complex drugs. Regul. Toxicol. Pharmacol. 2011: 59: 176-183
Supplementary files
